Plasminogen activator inhibitor 1 and 2 are tumor necrosis factor/cachectin-responsive genes
- PMID: 3137305
- PMCID: PMC2188989
- DOI: 10.1084/jem.168.2.751
Plasminogen activator inhibitor 1 and 2 are tumor necrosis factor/cachectin-responsive genes
Abstract
Human rTNF/Cachectin was shown to stimulate gene transcription of plasminogen activator inhibitor (PA1)-1 and PAI-2, and simultaneously suppress constitutive gene expression of tissue-type plasminogen activator (t-PA) in human fibrosarcoma cells. We propose that a TNF-mediated reprogramming of gene transcription induces, in appropriate target cells, an anti-fibrinolytic state, which may cooperate with the induction of procoagulant activity (tissue factor) to stabilize the fibrin deposits commonly found in inflamed tissue. PAI genes also provide a model system for a study of the molecular pathways underlying TNF-mediated signal transduction.
Similar articles
-
Glucocorticoid-modulated gene expression of tissue- and urinary-type plasminogen activator and plasminogen activator inhibitor 1 and 2.J Cell Biol. 1988 Mar;106(3):971-8. doi: 10.1083/jcb.106.3.971. J Cell Biol. 1988. PMID: 3126194 Free PMC article.
-
Interleukin-1, endotoxin or tumor necrosis factor/cachectin enhance the level of plasminogen activator inhibitor messenger RNA in bovine aortic endothelial cells.Thromb Res. 1989 Apr 1;54(1):41-52. doi: 10.1016/0049-3848(89)90335-6. Thromb Res. 1989. PMID: 2499077
-
The regulatory region of the human plasminogen activator inhibitor type-1 (PAI-1) gene.Nucleic Acids Res. 1988 Apr 11;16(7):2805-24. doi: 10.1093/nar/16.7.2805. Nucleic Acids Res. 1988. PMID: 3130610 Free PMC article.
-
Fibrinolysis in patients with acute ischaemic heart disease. With particular reference to systemic effects of tissue-type plasminogen activator treatment on fibrinolysis, coagulation and complement pathways.Dan Med Bull. 1993 Sep;40(4):383-408. Dan Med Bull. 1993. PMID: 8222763 Review.
-
Fibrinolytic system of cultured endothelial cells: regulation by plasminogen activator inhibitor.J Cell Biochem. 1986;32(4):273-80. doi: 10.1002/jcb.240320404. J Cell Biochem. 1986. PMID: 3100541 Review.
Cited by
-
Prognostic significance of proteolytic enzymes in human brain tumors.J Neurooncol. 1994;22(2):101-10. doi: 10.1007/BF01052886. J Neurooncol. 1994. PMID: 7538161 Review.
-
Genome scan of clot lysis time and its association with thrombosis in a protein C-deficient kindred.J Thromb Haemost. 2011 Jul;9(7):1383-90. doi: 10.1111/j.1538-7836.2011.04343.x. J Thromb Haemost. 2011. PMID: 21575129 Free PMC article.
-
Facultative polypeptide translocation allows a single mRNA to encode the secreted and cytosolic forms of plasminogen activators inhibitor 2.EMBO J. 1989 Nov;8(11):3287-94. doi: 10.1002/j.1460-2075.1989.tb08489.x. EMBO J. 1989. PMID: 2583099 Free PMC article.
-
Tumor necrosis factor: an update on basic research and clinical applications.Klin Wochenschr. 1990 Sep 3;68(17):841-6. doi: 10.1007/BF01662779. Klin Wochenschr. 1990. PMID: 2214607 Review.
-
Short-chain fatty acids induce tissue plasminogen activator in airway epithelial cells via GPR41&43.Clin Exp Allergy. 2018 May;48(5):544-554. doi: 10.1111/cea.13119. Epub 2018 Mar 24. Clin Exp Allergy. 2018. PMID: 29431874 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical